Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TXG | Class A Common Stock | Options Exercise | $51.6K | +10.2K | +21.72% | $5.04* | 57.3K | Nov 1, 2021 | Direct | F1 |
transaction | TXG | Class A Common Stock | Options Exercise | $361K | +31.4K | +54.81% | $11.48* | 88.8K | Nov 1, 2021 | Direct | F1 |
transaction | TXG | Class A Common Stock | Sale | -$177K | -1.1K | -1.24% | $160.50 | 87.7K | Nov 1, 2021 | Direct | F1, F2 |
transaction | TXG | Class A Common Stock | Sale | -$243K | -1.5K | -1.71% | $162.06 | 86.2K | Nov 1, 2021 | Direct | F1, F3 |
transaction | TXG | Class A Common Stock | Sale | -$1.93M | -11.8K | -13.73% | $163.15 | 74.4K | Nov 1, 2021 | Direct | F1, F4 |
transaction | TXG | Class A Common Stock | Sale | -$3.95M | -24.1K | -32.45% | $163.87 | 50.2K | Nov 1, 2021 | Direct | F1, F5 |
transaction | TXG | Class A Common Stock | Sale | -$513K | -3.11K | -6.2% | $164.75 | 47.1K | Nov 1, 2021 | Direct | F1, F6 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TXG | Stock Option (right to buy) | Options Exercise | $0 | -10.2K | -16.74% | $0.00 | 50.9K | Nov 1, 2021 | Class A Common Stock | 10.2K | $5.04 | Direct | F1, F7 |
transaction | TXG | Stock Option (right to buy) | Options Exercise | $0 | -31.4K | -31.43% | $0.00 | 68.6K | Nov 1, 2021 | Class A Common Stock | 31.4K | $11.48 | Direct | F1, F8 |
Id | Content |
---|---|
F1 | The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. |
F2 | This transaction was executed in multiple trades at prices ranging from $160.00 to $160.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F3 | This transaction was executed in multiple trades at prices ranging from $161.45 to $162.43. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F4 | This transaction was executed in multiple trades at prices ranging from $162.48 to $163.475. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F5 | This transaction was executed in multiple trades at prices ranging from $163.48 to $164.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F6 | This transaction was executed in multiple trades at prices ranging from $164.50 to $165.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
F7 | This option, originally for 175,000 shares, of which 124,116 shares have been exercised, vested as to 1/48th of the shares on October 1, 2018 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
F8 | This option, originally for 100,000 shares, of which 31,434 shares have been exercised, vested as to 1/48th of the shares on May 1, 2019 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
Chief Scientific Officer and President